Arbor

Arbor is a cutting-edge gene editing company that develops innovative therapeutics targeting a broad spectrum of genetic conditions, from rare diseases to more common genetic disorders. Their proprietary gene editing technologies surpass traditional methods, enabling access to new gene targets and driving a robust pipeline of groundbreaking treatments aimed at areas with significant unmet medical needs.